Shavadia, J., Zheng, Y., Green, J. B., Armstrong, P., Westerhout, C., McGuire, D., … Peterson, E. D. (2019). ASSOCIATIONS BETWEEN BETA-BLOCKER THERAPY AND CARDIOVASCULAR OUTCOMES IN PATIENTS WITH DIABETES AND ESTABLISHED ATHEROSCLEROTIC CARDIOVASCULAR DISEASE: INSIGHTS FROM THE TECOS STUDY. In Journal of the American College of Cardiology (Vol. 73, pp. 138–138). Elsevier BV. https://doi.org/10.1016/s0735-1097(19)30746-6

Shavadia, Jay, Yinggan Zheng, Jennifer B. Green, Paul Armstrong, Cynthia Westerhout, Darren McGuire, Matthew Roe, J. H. Cornel, Rury Holman, and Eric D. Peterson. “ASSOCIATIONS BETWEEN BETA-BLOCKER THERAPY AND CARDIOVASCULAR OUTCOMES IN PATIENTS WITH DIABETES AND ESTABLISHED ATHEROSCLEROTIC CARDIOVASCULAR DISEASE: INSIGHTS FROM THE TECOS STUDY.” In Journal of the American College of Cardiology, 73:138–138. Elsevier BV, 2019. https://doi.org/10.1016/s0735-1097(19)30746-6.

Shavadia J, Zheng Y, Green JB, Armstrong P, Westerhout C, McGuire D, et al. ASSOCIATIONS BETWEEN BETA-BLOCKER THERAPY AND CARDIOVASCULAR OUTCOMES IN PATIENTS WITH DIABETES AND ESTABLISHED ATHEROSCLEROTIC CARDIOVASCULAR DISEASE: INSIGHTS FROM THE TECOS STUDY. In: Journal of the American College of Cardiology. Elsevier BV; 2019. p. 138–138.

Shavadia, Jay, et al. “ASSOCIATIONS BETWEEN BETA-BLOCKER THERAPY AND CARDIOVASCULAR OUTCOMES IN PATIENTS WITH DIABETES AND ESTABLISHED ATHEROSCLEROTIC CARDIOVASCULAR DISEASE: INSIGHTS FROM THE TECOS STUDY.” Journal of the American College of Cardiology, vol. 73, no. 9, Elsevier BV, 2019, pp. 138–138. Crossref, doi:10.1016/s0735-1097(19)30746-6.

Shavadia J, Zheng Y, Green JB, Armstrong P, Westerhout C, McGuire D, Roe M, Cornel JH, Holman R, Peterson ED. ASSOCIATIONS BETWEEN BETA-BLOCKER THERAPY AND CARDIOVASCULAR OUTCOMES IN PATIENTS WITH DIABETES AND ESTABLISHED ATHEROSCLEROTIC CARDIOVASCULAR DISEASE: INSIGHTS FROM THE TECOS STUDY. Journal of the American College of Cardiology. Elsevier BV; 2019. p. 138–138.